PHILADELPHIA--(BUSINESS WIRE)--Richman Chemical, Inc. (RCI) today announced the commercial launch of Technology Assessment Reports (TAR’s) to assist technology start-ups, technology transfer offices (TTOs) and other emerging life science and specialty chemical businesses. The Technology Assessment Report will advise if a new technology is commercially feasible based on “as-is” production processes, while offering cost-effective production improvement strategies and recommendations for accelerated commercialization.
“University and Non-Profit technology transfer offices represent a significant market for such reports. These entities seek to license in-house technology to outside companies and investors, yet do not have the resources or expertise to evaluate commercial feasibility. Meanwhile, potential investors and partners prefer independent analysis that a technology is commercially viable before making the decision whether to invest,” commented Christopher Kulp, Executive Vice President at Richman Chemical. He continued, “Almost all start-up firms in the chemical and life science industries face similar challenges in developing and successfully commercializing their technologies.”
Help employers find you! Check out all the jobs and post your resume.
